In the BioHarmony Drug Report Database
Tranexamic acid
Cyklokapron, Lysteda, Tranexamic Acid (tranexamic acid) is a small molecule pharmaceutical. Tranexamic acid was first approved as Cyklokapron on 1986-12-30. It is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage in the USA. The pharmaceutical is active against plasminogen. Cyklokapron’s patent is valid until 2025-03-04 (FDA).
Trade Name
|
Cyklokapron, Lysteda, Tranexamic Acid |
|---|---|
Common Name
|
tranexamic acid |
ChEMBL ID
|
CHEMBL877 |
Indication
|
inherited blood coagulation disorders, subarachnoid hemorrhage |
Drug Class
|
Image (chem structure or protein)